Nom du produit:5-(4-methylbenzyl)-7-(trifluoromethyl)-1,2,3,3a-tetrahydropyrrolo[1,2-a]quinoxalin-4(5H)-one

IUPAC Name:5-[(4-methylphenyl)methyl]-7-(trifluoromethyl)-1H,2H,3H,3aH,4H,5H-pyrrolo[1,2-a]quinoxalin-4-one

CAS:1009537-73-8
Formule moléculaire:C20H19F3N2O
Pureté:95%+
Numéro de catalogue:CM1050305
Poids moléculaire:360.38

Unité d'emballage Stock disponible Prix($) Quantité
CM1050305-10mg in stock Ɠůʼn

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1009537-73-8
Formule moléculaire:C20H19F3N2O
Point de fusion:-
Code SMILES:O=C1N(C2=CC(C(F)(F)F)=CC=C2N3C1CCC3)CC4=CC=C(C)C=C4
Densité:
Numéro de catalogue:CM1050305
Poids moléculaire:360.38
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.